ValGenesis to Showcase AI-enabled Digital Validation at BioProcessing Summit Europe 2026

Audio By Carbonatix

SANTA CLARA, Calif.--(BUSINESS WIRE)--Feb 23, 2026--

ValGenesis Inc., the global leader in digital validation lifecycle management, will showcase its AI-enabled Smart GxP™ platform at BioProcessing Summit Europe 2026, taking place March 10-12 in Barcelona, Spain. The event brings together bioprocessing innovators, scientists, and decision-makers advancing the future of modern biomanufacturing.

At Booth No. 35, ValGenesis will demonstrate how life sciences organizations are using the platform to modernize development, commissioning, qualification, and validation (CQV), and continued process verification (CPV) across the product lifecycle. By digitalizing these critical processes, ValGenesis Smart GxP™ helps companies reduce risk, improve operational efficiency, and accelerate the delivery of high-quality therapies to market.

“BioProcessing Summit Europe provides a valuable opportunity to engage directly with the innovators shaping the future of biomanufacturing,” said Steve Reynolds, chief revenue officer at ValGenesis. “We look forward to sharing how AI-enabled validation simplifies complexity, strengthens compliance, and delivers measurable operational impact.”

ValGenesis regularly participates in global industry events and forums as part of its commitment to supporting customers across North America, Europe, Latin America, and Asia-Pacific. Through these engagements, the company collaborates with life sciences organizations to address evolving regulatory expectations and operational challenges.

Why visit Booth No. 35?

• Live demonstrations of the ValGenesis Smart GxP™ platform
• Insights on accelerating digital transformation in validation
• One-one-one consultations tailored to organizational maturity and compliance goals
• Strategic discussions on leveraging AI to enhance quality, reduce risk, and improve lifecycle visibility

Stop by Booth No. 35 to schedule a one-on-one conversation with the ValGenesis team.

About ValGenesis Inc.

ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ Platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit https://www.valgenesis.com/.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260223817849/en/

Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 [email protected]

KEYWORD: EUROPE SPAIN UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: SOFTWARE RESEARCH GENERAL HEALTH PROFESSIONAL SERVICES DATA MANAGEMENT TECHNOLOGY ARTIFICIAL INTELLIGENCE HEALTH TECHNOLOGY DATA ANALYTICS SCIENCE BIOTECHNOLOGY HEALTH

SOURCE: ValGenesis Inc.

Copyright Business Wire 2026.

PUB: 02/23/2026 09:00 AM/DISC: 02/23/2026 09:00 AM

http://www.businesswire.com/news/home/20260223817849/en